02279 雍禾醫療
按盘价 
1.280 +0.010 (+0.787%) 盈利能力分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 资产回报率 (%) | -10.854% | -20.331% | -2.801% | 5.014% | 12.934% |
| 股东资金回报率 (%) | -27.321% | -43.230% | -5.229% | 11.423% | 50.632% |
| 资本运用回报率 (%) | -19.174% | -31.736% | -3.531% | 4.882% | 14.996% |
边际利润分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 毛利率 (%) | 60.084% | 56.108% | 61.763% | 72.858% | 74.567% |
| 未计利息、税项、折旧及摊销前利润率 (%) | -12.452% | -11.079% | 4.463% | 21.077% | 25.965% |
| 税前边际利润率 (%) | -14.147% | -32.928% | -7.748% | 9.696% | 14.095% |
| 纯利率 (%) | -12.543% | -30.744% | -6.077% | 5.542% | 9.970% |
变现能力分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 流动比率 (X) | 1.154 X | 1.120 X | 2.386 X | 2.370 X | 0.866 X |
| 速动比率 (X) | 1.080 X | 1.014 X | 2.209 X | 2.298 X | 0.813 X |
财务杠杆分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 总负债 / 总资产比率 (%) | 58.648% | 61.455% | 45.901% | 46.915% | 74.532% |
| 总债项 / 总资产比率 (%) | 38.648% | 44.816% | 35.340% | 31.930% | 53.677% |
| 净债项 / 总资产比率 (%) | 10.387% | 20.140% | 16.056% | -17.024% | 35.309% |
| 总债项 / 股东资金比率 (%) | 93.392% | 116.232% | 65.325% | 60.149% | 210.758% |
| 长期债项 / 股东资金比率 (%) | 65.310% | 81.978% | 53.305% | 44.885% | 168.173% |
| 净债项 / 股东资金比率 (%) | 25.099% | 52.234% | 29.679% | -32.070% | 138.636% |
| 净现金 / (债项) ($) | (1.79亿) | (4.92亿) | (4.71亿) | 5.45亿 | (5.63亿) |
| 每股净现金 / (债项) ($) | (0.341) | (0.934) | (0.893) | 1.048 | -- |
| 总债项 / 资本运用比率 (%) | 56.514% | 63.634% | 42.585% | 41.498% | 78.575% |
| 利息盈利率 (X) | N/A | N/A | N/A | 5.048 X | 7.363 X |
营运效率分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 存货周转率日数 (日) | 29.528日 | 38.390日 | 47.711日 | 24.846日 | 18.169日 |
| 应收贸易帐周转率日数 (日) | 1.507日 | 1.779日 | 2.636日 | 1.993日 | 1.803日 |
| 应付贸易帐周转率日数 (日) | 12.571日 | 12.670日 | 10.338日 | 6.794日 | 7.488日 |
| 备注： | 实时报价更新时间为16/05/2025 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) (千) | RMB -226,343 |
| 增长率 | -58.575% |
| 每股盈利/(亏损) | RMB -0.450 |
| 每股账面资产净值 (¥) | RMB 1.360 |